A Tick Protein with a Modified Kunitz Fold Inhibits Human Tryptase

Journal of Molecular Biology

Volumn 368, Issue 4, 2007, Pages 1172-1186

  Paesen, Guido C ^a   Siebold, Christian ^b   Harlos, Karl ^b   Peacey, Mick F ^a   Nuttall, Patricia A ^a   Stuart, David I ^b  

^a CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^b Division of Structural Biology   (United Kingdom)

Author keywords

Kunitz; structure; tick; trypsin; tryptase

Indexed keywords

TICK DERIVED PROTEASE INHIBITOR; TRYPSIN; TRYPTASE; TRYPTASE INHIBITOR; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOSOL; DISULFIDE BOND; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVE SITE; MAST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION;

ANIMALIA; IXODIDA;

EID: 34247123987     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.03.011     Document Type: Article

References (49)

1. Cairns J.A. Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders. Pulm. Pharmacol. Ther. 18 (2005) 55-66
2. Pereira P.J., Bergner A., Macedo-Ribeiro S., Huber R., Matschiner G., Fritz H., et al. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392 (1998) 306-331
3. Sommerhoff C.P., Söllner C., Mentele R., Piechottka G.P., Auerswald E.A., and Fritz H. A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. Biol. Chem. Hoppe-Seyler 375 (1994) 685-694
4. Brossard M., and Wikel S.K. Tick immunobiology. Parasitology 129 (2004) S161-S176
5. Van de Locht A., Stubbs M.T., Bode W., Friedrich T., Bollschweiler C., Höffken W., and Huber R. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?. EMBO J. 15 (1996) 6011-6017
6. Peng Q., McEuen A.R., Benyon R.C., and Walls A.F. The heterogeneity of mast cell tryptase from human lung and skin. Eur. J. Biochem. 270 (2003) 270-283
7. De Young M.B., Nemeth E.F., and Scarpa A. Measurement of the internal pH of mast cell granules using microvolumetric fluorescence and isotopic techniques. Arch. Biochem. Biophys. 254 (1987) 222-233
8. Hallgren J., Bäckström S., Estrada S., Thuveson M., and Pejler G. Histidines are critical for heparin-dependent activation of mast cell tryptase. J. Immunol. 173 (2004) 1868-1875
9. Schechter I., and Berger A. On the size of the active site in proteases. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
10. Laskowski Jr. M., and Kato I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 49 (1980) 593-626
11. MacLean II J.A., Roberts R.M., and Green J.A. Atypical Kunitz-type serine proteinase inhibitors produced by the ruminant placenta. Biol. Reprod. 71 (2004) 455-463
12. Stubbs M.T., Morenweiser R., Sturzebecher J., Bauer M., Bode W., Huber R., et al. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J. Biol. Chem. 272 (1997) 19931-19937
13. Bergstresser P.R., Tigelaar R.E., and Tharp M.D. Conjugated avidin identifies cutaneous rodent and human mast cells. J. Invest. Dermatol. 83 (1984) 214-218
14. Ikeo K., Takahashi K., and Gojobori T. Evolutionary origin of a Kunitz-type trypsin inhibitor domain inserted in the amyloid beta precursor protein of Alzheimer's disease. J. Mol. Evol. 34 (1992) 536-543
15. Mans B.J., Louw A.I., and Neitz A.W. Evolution of hematophagy in ticks: common origins for blood coagulation and platelet aggregation inhibitors from soft ticks of the genus Ornithodoros. Mol. Biol. Evol. 19 (2002) 1695-1705
16. Wei A., Alexander R.S., Duke J., Ross H., Rosenfeld S.A., and Chang C.H. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. J. Mol. Biol. 283 (1998) 147-154
17. Huang C., Morales G., Vagi A., Chanasyk K., Ferrazzi M., Burklow C., et al. Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface. J. Biol. Chem. 275 (2000) 351-358
18. Hoogerwerf W.A., Zou L., Shenoy M., Sun D., Micci M.A., Lee-Hellmich H., et al. The proteinase-activated receptor 2 is involved in nociception. J. Neurosci. 21 (2001) 9036-9042
19. Miike S., McWilliam A.S., and Kita H. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. J. Immunol. 167 (2001) 6615-6622
20. Rubaire-Akiiki C.M., and Mutinga M.J. The histology of the skin reaction associated with rabbit resistance to Rhipicephalus appendiculatus (Neumann) infestations. Bull. Anim. Health Prod. Afr. 28 (1980) 35-47
21. Paesen G.C., Adams P.L., Harlos K., Nuttall P.A., and Stuart D.I. Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol. Cell 3 (1999) 661-671
22. Henz B.M., Maurer M., Lippert U., Worm M., and Babina M. Mast cells as initiators of immunity and host defense. Exp. Dermatol. 10 (2001) 1-10
23. Rickard A., and Lagunoff D. Eosinophil peroxidase accounts for most if not all of the peroxidase activity associated with isolated rat peritoneal mast cells. Int. Arch. Allergy Immunol. 103 (1994) 365-369
24. He S., McEuen A.R., Blewett S.A., Li P., Buckley M.G., Leufkens P., and Walls A.F. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem. Pharmacol. 65 (2003) 1007-1015
25. Kido H., Fukusen N., and Katunuma N. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release. Biol. Chem. Hoppe-Seyler 369 (1988) 95-100
26. Ide H., Itoh H., Yoshida E., Kobayashi T., Tomita M., Maruyama H., et al. Immunohistochemical demonstration of inter-alpha-trypsin inhibitor light chain (bikunin) in human mast cells. Cell Tiss. Res. 297 (1999) 149-154
27. Enomoto A., Murakami M., and Kudo I. Internalization and degradation of type IIA phospholipase A(2) in mast cells. Biochem. Biophys. Res. Commun. 276 (2000) 667-672
28. Gervasoni J.E.J., Conrad D.H., Hugli T.E., Schwartz L.B., and Ruddy S. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan. J. Immunol. 136 (1986) 285-292
29. Hafez M.M., and Costlow M.E. Prolactin binding and localization in rat mammary tumor mast cells. Cancer Res. 48 (1988) 3765-3771
30. Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., and Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell 8 (1997) 2631-2645
31. Sakai K., Long S.D., Pettit D.A., Cabral G.A., and Schwartz L.B. Expression and purification of recombinant human tryptase in a baculovirus system. Protein Expr. Purif. 7 (1996) 67-73
32. Okayama Y., el-Lati S.G., Leiferman K.M., and Church M.K. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J. Allergy Clin. Immunol. 93 (1994) 900-909
33. He S., Aslam A., Gaca M.D., He Y., Buckley M.G., Hollenberg M.D., and Walls A.F. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. J. Pharmacol. Exp. Ther. 309 (2004) 119-126
34. Chase T., and Shaw E. Titration of trypsin, plasmin, and thrombin with, p-nitrophenyl, p′-guanidinobenzoate HCl. Methods Enzymol. 19 (1970) 20-27
35. i values for tight binding inhibitors from dose-response plots. Bioorg. Med. Chem. Letters 5 (1995) 1947-1952
36. Nicklin M.J., and Barrett A.J. Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem. J. 223 (1984) 245-253
37. Van Duyne G.D., Standaert R.F., Karplus P.A., Schreiber S.L., and Clardy J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229 (1993) 105-124
38. Walter T.S., Diprose J.M., Mayo C.J., Siebold C., Pickford M.G., Carter L., et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallog. sect. D 61 (2005) 651-657
39. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
40. Schneider T.R., and Sheldrick G.M. Substructure solution with SHELXD. Acta Crystallog. sect. D 58 (2002) 1772-1779
41. Sheldrick G.M. Macromolecular phasing with SHELXE. Z. Kristallog. 217 (2002) 644-650
42. Perrakis A., Morris R., and Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nature Struct. Biol. 6 (1999) 458-463
43. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
44. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallog. sect. D 53 (1997) 240-255
45. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallog. sect. D 61 (2005) 458-464
46. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallog. sect. D 60 (2004) 2126-2132
47. Laskowski R.A., MacArthur M.W., and Thornton J.M. Evaluation of protein coordinate data sets. In: Bailey S., Hubbard R., and Waller D.A. (Eds). From First Map to Final Model, Proceedings of the CCP4 study weekend (1994), Daresbury Laboratory, Warrington, UK
48. Stuart D.I., Levine M., Muirhead H., and Stammers D.K. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å. J. Mol. Biol. 134 (1979) 109-142
49. Nicholls A., Sharp K.A., and Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11 (1991) 281-296